Tumor lysis syndrome in an infant with Langerhans cell histiocytosis successfully treated using continuous arteriovenous hemofiltration.
J Pediatr Hematol Oncol
; 23(2): 142-4, 2001 Feb.
Article
in En
| MEDLINE
| ID: mdl-11216709
ABSTRACT
Langerhans cell histiocytosis (LCH) is an enigmatic disease usually occurring in children. Tumor lysis syndrome (TLS) is a clinical syndrome associated with severe metabolic derangement and oliguric acute renal failure. In this report, we present the clinical course of an infant with advanced LCH who had TLS develop after chemotherapy. Treatment with continuous arteriovenous hemofiltration resulted in effective control of serum uric acid, potassium, creatinine, phosphorus, and blood urea nitrogen levels in the blood.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Orbital Diseases
/
Temporal Bone
/
Tumor Lysis Syndrome
/
Antineoplastic Combined Chemotherapy Protocols
/
Histiocytosis, Langerhans-Cell
/
Hemofiltration
Type of study:
Etiology_studies
Limits:
Female
/
Humans
/
Infant
Language:
En
Journal:
J Pediatr Hematol Oncol
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
/
PEDIATRIA
Year:
2001
Document type:
Article
Affiliation country: